These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Nuclear transcription factors and lipid homeostasis in liver. Chen YX; Huang AL; Ruan XZ Chin Med J (Engl); 2007 Dec; 120(24):2290-6. PubMed ID: 18167220 [No Abstract] [Full Text] [Related]
23. The functional efficiency of lipogenic and cholesterogenic gene expression in normal mice and in mice lacking the peroxisomal proliferator-activated receptor-alpha (PPAR-alpha). Gibbons GF; Patel D; Wiggins D; Knight BL Adv Enzyme Regul; 2002; 42():227-47. PubMed ID: 12123718 [No Abstract] [Full Text] [Related]
24. Lipid metabolism: peroxisome proliferator-activated receptor-alpha and atherosclerosis. van Greevenbroek MM; van der Kallen CJ Curr Opin Lipidol; 2002 Apr; 13(2):223-5. PubMed ID: 11891425 [No Abstract] [Full Text] [Related]
25. Peroxisome proliferator-activated receptors: a nuclear hormone receptor involved in adipocyte differentiation and lipid homeostasis. Shalev A; Meier CA Eur J Endocrinol; 1996 May; 134(5):541-2. PubMed ID: 8664970 [No Abstract] [Full Text] [Related]
26. Peroxisome proliferator-activated receptors: mediators of a fast food impact on gene regulation. Gelman L; Auwerx J Curr Opin Clin Nutr Metab Care; 1999 Jul; 2(4):307-12. PubMed ID: 10453311 [TBL] [Abstract][Full Text] [Related]
27. The role of peroxisome proliferator activated receptor alpha in peroxisome proliferation, physiological homeostasis, and chemical carcinogenesis. Gonzalez FJ Adv Exp Med Biol; 1997; 422():109-25. PubMed ID: 9361819 [No Abstract] [Full Text] [Related]
29. Peroxisomal proliferate-activated receptors and the regulation of lipid oxidation and adipogenesis. Smith SA Biochem Soc Trans; 1997 Nov; 25(4):1242-8. PubMed ID: 9449984 [No Abstract] [Full Text] [Related]
31. Complex connection between CD36 and atherosclerosis, lipid metabolism, and insulin resistance syndromes. Gotoda T; Iizuka Y; Yamada N Curr Atheroscler Rep; 2000 Nov; 2(6):453-4. PubMed ID: 11122778 [No Abstract] [Full Text] [Related]
32. Biliary lipid secretion, membrane pumps, and the metabolic response to fasting: distinct PPAR-ts of a common regulatory pathway. Newberry EP; Davidson NO Gastroenterology; 2003 Jan; 124(1):254-7. PubMed ID: 12512050 [No Abstract] [Full Text] [Related]
33. Peroxisome proliferator-active receptor gamma: a legitimate target to control pulmonary inflammation? Riches DW Am J Respir Crit Care Med; 2004 Jan; 169(2):145-6. PubMed ID: 14718232 [No Abstract] [Full Text] [Related]
36. Recent advances in our understanding of insulin action and insulin resistance. Le Roith D; Zick Y Diabetes Care; 2001 Mar; 24(3):588-97. PubMed ID: 11289486 [No Abstract] [Full Text] [Related]
37. [Mechanism of the onset and development of nonalcoholic steatohepatitis and PPAR]. Tanaka N; Aoyama T Nihon Shokakibyo Gakkai Zasshi; 2002 Jun; 99(6):563-9. PubMed ID: 12099000 [No Abstract] [Full Text] [Related]
38. Fraudulent (and non fraudulent) fatty acids for human health. Sirtori CR; Galli C; Franceschini G Eur J Clin Invest; 1993 Nov; 23(11):686-9. PubMed ID: 8307087 [No Abstract] [Full Text] [Related]
39. Prostaglandin and PPAR control of immune cell function. Rotondo D; Davidson J Immunology; 2002 Jan; 105(1):20-2. PubMed ID: 11849311 [No Abstract] [Full Text] [Related]
40. Is there a role for PPAR gamma in IBD? Yes, no, maybe. Wu GD Gastroenterology; 2003 May; 124(5):1538-42. PubMed ID: 12730893 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]